Lupin Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Lupin Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 69% in 3 years; of every extra ₹100 of sales, ₹44 became extra profit. Higher than 90% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹133Over the last 3 years, every ₹100 of reported profit came with ₹133 of operating cash.
Higher than 64% of Healthcare companies in India.
Self-Funding Ratio
3.0×Over the last 3 years its own operating cash covered its investment spending (capex) 3.0 times.
Higher than 81% of Healthcare companies in India.
Cash Locked Ratio
₹21For every ₹100 of sales, ₹21 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹31 tied up three years earlier.
Less money tied up than 55% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹44Sales grew 69% in 3 years; of every extra ₹100 of sales, ₹44 became extra profit.
Higher than 90% of Healthcare companies in India.
Asset Productivity Ratio
+69% / +67%In 3 years sales changed by +69% while total assets changed by +67%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
1.7×Debt due within a year is covered 1.7 times by its yearly operating cash.
Higher than 57% of Healthcare companies in India.
Cash Cushion Ratio
+2%Cash, after subtracting all debt, equals 2% of its market value (net cash).
Higher than 67% of Healthcare companies in India.
Tangible Assets Ratio
85%Of every ₹100 the company owns, ₹85 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 77% of Healthcare companies in India.
Tangible Net Worth Ratio
74%Of every ₹100 of net worth, ₹74 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 77% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Lupin Limited owes ₹0.41 for every ₹1 it owns. Net profit rose 63% in the year to Mar 2026, and grew 131% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
15.9Investors pay ₹15.9 for every ₹1 of Lupin Limited's yearly profit, lower than 89% of Healthcare companies in India.
P/B ratio
3.92The share price is 3.92 times Lupin Limited's book value per share, lower than 61% of Healthcare companies in India.
Market cap
₹87,891 CrThe total market value of all of Lupin Limited's shares at today's price (share price × number of shares), larger than 93% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹22,448 CrWhat Lupin Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹490.90Net worth divided by the number of shares. The share price of ₹1,922 is 3.9 times this, which is the P/B above.
Return on equity (ROE)
24.6%Lupin Limited earned 24.6% on its shareholders' money over the last year, higher than 87% of Healthcare companies in India.
Owes vs Owns
0.41×Lupin Limited owes ₹0.41 for every ₹1 it owns (low), higher than 63% of Healthcare companies in India.
Dividend yield
0.93%Lupin Limited pays 0.93% of its share price as dividends a year, higher than 79% of dividend-paying Healthcare companies in India.
Revenue growth
+24%Revenue rose 24% in the year to Mar 2026, and grew 19% a year on average over 3 years.
Profit growth
+63%Net profit rose 63% in the year to Mar 2026, and grew 131% a year on average over 3 years.
Profit margin
19.4%Lupin Limited keeps ₹19 of every ₹100 of revenue as net profit.
Cash quality
1.4×Cash from Lupin Limited's business was 1.4× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
16.5×Lupin Limited's operating profit covered its interest costs 16.5 times in the year to Mar 2026.
Cash vs debt
Net cashLupin Limited held ₹1,332 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Lupin Limited's P/E ratio?
Investors pay ₹15.9 for every ₹1 of Lupin Limited's yearly profit, lower than 89% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Lupin Limited: ₹87,891 Cr ÷ ₹22,448 Cr (31 Mar 2026) = 3.9.
What is Lupin Limited's return on equity?
Lupin Limited earned 24.6% on its shareholders' money over the last year, higher than 87% of Healthcare companies in India.
How much does Lupin Limited owe compared with what it owns?
Lupin Limited owes ₹0.41 for every ₹1 it owns (low), higher than 63% of Healthcare companies in India.
Does Lupin Limited pay a dividend?
Yes. Lupin Limited pays 0.93% of its share price as dividends a year, higher than 79% of dividend-paying Healthcare companies in India.
Is Lupin Limited's revenue growing?
Revenue rose 24% in the year to Mar 2026, and grew 19% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.